Xinwen Wang
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
RP11-738E22.3 promotes hepatocellular carcinoma progression by inhibiting autophagy and apoptosis via MAPK/ERK/mTOR pathway.
Journal: International journal of biological macromolecules
Published: October 18, 2025
Multi-omics insights for deciphering prognosis-related T cell subsets in hepatocellular carcinoma.
Journal: Clinical and translational medicine
Published: October 17, 2025
The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma.
Journal: Scientific reports
Published: January 31, 2025
The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: November 20, 2024
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.
Journal: Hepatology (Baltimore, Md.)
Published: September 30, 2023
A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.
Journal: Biological procedures online
Published: February 28, 2023
Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
Journal: Computers in biology and medicine
Published: November 16, 2022
tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 05, 2021
MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026